MyChart
Our oncology pharmacy residency program helps residents develop expertise and competency in providing pharmaceutical care services to cancer patients in both inpatient and ambulatory settings. Required rotations include adult and pediatric oncology, bone marrow transplant, oral chemotherapy, infusion and hospice/palliative care. Longitudinal experiences include administration, research, tumor board attendance, participation in an oncology pharmacy and therapeutics (P&T) committee. Residents will also have opportunities to teach through direct precepting of PGY1 residents and students as well as opportunities to lecture in the oncology module and participate in the oncology elective at Idaho State University.
This 12-month program offers an approximately $50,000 stipend, benefits, and paid time off.
Residency Start Date: July 6, 2020
Core Rotations
- Orientation - 2 weeks
- Medical oncology/infusion - 6 weeks
- Oral chemotherapy - 6 weeks
- Inpatient oncology - 5 weeks
- Blood and marrow transplant - 5 weeks
- Pediatric oncology - 5 weeks
- Hospice/palliative care - 4 weeks
- Precepting - 4 weeks
Modified Rotations
- Radiation oncology (Nampa) - 3 weeks
- Rural oncology (Fruitland) - 1 week
- Elective option - 4 weeks
Longitudinal Rotations
-
Oncology research (with concentrated opportunities)
-
Oncology administration (with additional concentrated rotation elective available)
-
Project time
-
Staffing
Projects
Resident will complete numerous projects throughout the residency year and select one major project to present at the Western States Residency Conference. This will include an abstract and 15 minute power point presentation. After returning from Western States, the project will be written in manuscript form prior to residency completion. The resident will select one preceptor to serve as a mentor for the major residency project. The resident and the preceptor will meet on a regular basis to discuss details of the project, timelines, obstacles and accomplishments. Major project timeline:- Project ideas & discussion – Nov 1
- Project selection – Dec 1
- Timeline – Dec 1
- Goals & objectives – Dec 15
- Abstract (rough draft) for Western States Residency Conference – Jan 15
- PowerPoint presentation (rough draft) – April 15
Staffing & Other Activities
- Opportunity to serve as the primary preceptor for one P4 student and/or one PGY1 resident
- Assist in updating the current rotation materials
- Schedule rotation activities
- Oversee all projects done by the student/resident and ensure deadlines are met
- Contribute to the evaluation of the student/resident
Application Requirements and Process
Application Deadline: January 3, 2020
Applicants must have a PharmD degree or equivalent, eligibility for Idaho licensure, CV, 3 letters of recommendation (1 from PGY1 RPD) and completion of PGY1 residency. Please visit the link below to apply:
Contact Information
For questions, please contact:
Robert Mancini, PharmD, BCOP
PGY2 Residency Program Director
Phone: (208) 381-4141
Email: mancinir@slhs.org
Accreditation
The PGY2 Oncology Pharmacy Residency conducted by St. Luke's Health System, Boise, ID is accredited by ASHP.